What is NDC 39822-0706?

39822-0706 is the product NDC for Streptomycin, Streptomycin sulfate 1 g/1 injection, powder, lyophilized, for solution, listed with the FDA by XGen Pharmaceuticals DJB, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

XGen Pharmaceuticals DJB, Inc., NDC labeler code 39822. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Streptomycin?

None: this is the only finished product listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Streptomycin NDC 39822-0706 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)39822-0706Labeler and product segments. Claims need a package NDC.

Product NDC at billing width39822-0706Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
39822-0706-2	39822070602	10 VIAL in 1 BOX (39822-0706-2) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (39822-0706-1)Marketed from Jun 30, 1998

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Streptomycin
Generic name (nonproprietary): streptomycin
Active ingredients: Streptomycin sulfate — 1 g/1
Dosage form: Injection, Powder, Lyophilized, For solution
Route: Intramuscular
Labeler: XGen Pharmaceuticals DJB, Inc.NDC labeler code 39822
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 064210
Marketing start: Jun 30, 1998
Listing expires: Dec 31, 2027
Other FDA classes: Aminoglycosides (Chemical structure)
Identifiers: Product ID 39822-0706_48eb47bf-4135-a8cf-e063-6394a90a4d2dSPL ID 48eb47bf-4135-a8cf-e063-6394a90a4d2dSPL set ID abd1f64e-4283-4370-aae8-3666316aa36eRxCUI 313115UNII CW25IKJ202UPC 0339822070626, 0339822070619
Pharmacologic class: Aminoglycoside Antibacterial; Antimycobacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N439822070602 followed by a unit qualifier and the quantity

Package 39822-0706-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 21, 2026. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Streptomycin is indicated for the treatment of individuals with moderate to severe infections caused by susceptibile strains of microorganisms in the specific conditions listed below: 1. Mycobacterium tuberculosis: The Advisory Council for the Elimination of Tuberculosis, the American Thoracic Society, and the Center for Disease Control recommend that either streptomycin or ethambutol be added as a fourth drug in a regimen containing isoniazid (INH), rifampin and pyrazinamide for initial treatment of tuberculosis unless the likelihood of INH or rifampin resistance is very low. The need for a fourth drug should be reassessed when the results of susceptibility testing are…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 39822-0706

What is NDC 39822-0706?: 39822-0706 is the product NDC for Streptomycin, Streptomycin sulfate 1 g/1 injection, powder, lyophilized, for solution, listed with the FDA by XGen Pharmaceuticals DJB, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Streptomycin.
What is the active ingredient?: Streptomycin sulfate.
Who is the labeler?: XGen Pharmaceuticals DJB, Inc., NDC labeler code 39822. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Streptomycin?: None: this is the only finished product listed under this name.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.